Search

Your search keyword '"Salvesen, HB"' showing total 247 results

Search Constraints

Start Over You searched for: Author "Salvesen, HB" Remove constraint Author: "Salvesen, HB"
247 results on '"Salvesen, HB"'

Search Results

1. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

2. Adult height is associated with increased risk of ovarian cancer: A Mendelian randomisation study

3. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

4. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci

5. Five endometrial cancer risk loci identified through genome-wide association analysis

6. A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 Binding

7. Evaluating the ovarian cancer gonadotropin hypothesis: A candidate gene study

8. Adult body mass index and risk of ovarian cancer by subtype: A Mendelian randomization study

9. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

10. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

11. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

12. Risk of ovarian cancer and the NF-kB pathway: Genetic association with IL1A and TNFSF10

13. Low frequency of BRAF and CDKN2A mutations in endometrial cancer

14. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

15. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

16. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC).

17. Identification of six new susceptibility loci for invasive epithelial ovarian cancer

18. Genome-wide significant risk associations for mucinous ovarian carcinoma

19. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer

20. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

21. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1

22. Integrated genomic characterization of endometrial carcinoma

23. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

24. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

25. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

26. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

27. MDM2 Promoter SNP344T > A (rs1196333) Status Does Not Affect Cancer Risk

29. Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome.

30. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

31. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

32. BRCA2 Polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

33. GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.

34. Novel PCDH10-Wnt-MALAT1 regulatory axis in endometrioid endometrial adenocarcinoma.

35. Influence of p53 Isoform Expression on Survival in High-Grade Serous Ovarian Cancers.

36. PIK3CA Amplification Associates with Aggressive Phenotype but Not Markers of AKT-MTOR Signaling in Endometrial Carcinoma.

37. Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer.

38. Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.

39. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study.

40. White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk.

41. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study.

42. HER2 expression patterns in paired primary and metastatic endometrial cancer lesions.

43. Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach.

44. Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.

45. Expression of glucocorticoid receptor is associated with aggressive primary endometrial cancer and increases from primary to metastatic lesions.

46. Type of vascular invasion in association with progress of endometrial cancer.

47. Cerebellar degeneration-related proteins 2 and 2-like are present in ovarian cancer in patients with and without Yo antibodies.

48. High visceral fat percentage is associated with poor outcome in endometrial cancer.

49. A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway.

50. Clinicopathologic and molecular markers in cervical carcinoma: a prospective cohort study.

Catalog

Books, media, physical & digital resources